<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Capimune; Ciclosporin: immunosuppression" /><meta name="IX" content="Capimune; Ciclosporin: immunosuppression" /><title>Capimune®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="213793.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="213793.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=213793.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2075.htm">8 Malignant disease and immunosuppression</a> &gt; <a href="4777.htm">8.2 Drugs affecting the immune response</a> &gt; <a href="4782.htm">8.2.2 Corticosteroids and other immunosuppressants</a> &gt; <a href="4783.htm">CICLOSPORIN</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="217026.htm" title="Previous: BELATACEPT">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="106034.htm" title="Next: SIROLIMUS">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a303001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cyclosporine (EENT)</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Eye, Ear, Nose, and Throat (EENT) Preparations 52:00 &gt; Anti-inflammatory Agents 52:08 &gt; EENT Anti-inflammatory Agents, Miscellaneous 52:08.92</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a384054.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cyclosporine</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Miscellaneous Therapeutic Agents 92:00 &gt; Immunosuppressive Agents 92:44</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/1882-m.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Ciclosporin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: C &gt; Interactions of Ciclosporin</p></div></li></ul><ul><li><h3>British National Formulary (13)</h3></li><li><a href="100022.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Inflammatory bowel disease</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders</p></div></li><li><a href="201296.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">CICLOSPORIN</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders &gt; 1.5.3 Drugs affecting the immune response</p></div></li><li><a href="4782.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">8.2.2 Corticosteroids and other immunosuppressants</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22ciclosporin%22%22ciclosporin%22%22ciclosporin%22%22cyclosporin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (13)</a></li></ul><ul><li><h3>BNF for Children (10)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/100022.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Inflammatory bowel disease</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/201978.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">1.5.3 Drugs affecting the immune response</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/129294.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">CICLOSPORIN</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders &gt; 1.5.3 Drugs affecting the immune response</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22ciclosporin%22%22ciclosporin%22%22ciclosporin%22%22cyclosporin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (10)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0367.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ciclosporin</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; C</p></div></li></ul><ul><li><h3>Dietary Supplements</h3></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c77.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Potassium</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; P</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a585014.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cyclosporine</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; C</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0003s0730.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cyclosporine</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; C</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/c19-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ciclosporin (cyclosporine, cyclosporin)</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; C</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/1882-m.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ciclosporin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Immunosuppressants &gt; Drug Monographs</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E36E3E0R0D447.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Ciclosporin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; C</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c82.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ciclosporin</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; C</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_4783">CICLOSPORIN</h1><div id="pC" class="jN"><h2 class="cBO">(Cyclosporin)</h2><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i499.htm" title="Go to appendix 1">Ciclosporin</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF"><a title="target-block: CICLOSPORIN NOTES " href="4782.htm#_1199892242929">see notes above</a>, and under Dose; severe acute ulcerative colitis [unlicensed indication]
(section <a title="BNF:monograph: CICLOSPORIN" href="201296.htm#_201296">1.5.3</a>); rheumatoid arthritis (<a title=" Drugs which suppress the rheumatic disease process" href="5288.htm#_5288">section 10.1.3</a>); atopic
dermatitis and psoriasis (<a title="sub-section: Drugs affecting the immune response" href="106473.htm#_106473">section 13.5.3</a>)</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF"><span id="_6000.2">monitor kidney function—dose dependent increase in serum creatinine and urea during first
few weeks may necessitate dose reduction in transplant patients (exclude
rejection if kidney transplant) or discontinuation in non-transplant
patients; monitor liver function (see Hepatic
Impairment below); monitor blood pressure—discontinue if hypertension develops that cannot be
controlled by antihypertensives; hyperuricaemia; monitor serum potassium especially in renal dysfunction (risk of hyperkalaemia); monitor serum magnesium; measure blood
lipids before treatment and after the first month of treatment; </span><span id="_4783.4">use with <span>tacrolimus</span> specifically contra-indicated; for patients other than transplant
recipients, preferably avoid other immunosuppressants (increased risk
of infection and malignancies, including lymphoma and skin cancer); avoid excessive exposure to UV
light, including sunlight; <b>interactions: </b>Appendix 1 (<span>ciclosporin</span>)</span></p><div class="cAV"><h3>Additional cautions in nephrotic syndrome</h3> <p class="cAX"><span id="_4783.1"><b><i>Contra-indicated</i> </b> in uncontrolled hypertension, uncontrolled infections, and malignancy; in long-term management, perform renal biopsies at yearly intervals</span></p></div></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">dosage adjustment based on bilirubin and liver enzymes
may be needed</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">dose as in normal renal function but see Cautions above;
in nephrotic syndrome reduce dose by 25–50% if serum creatinine more
than 30% above baseline on more than one measurement; in patients
with nephrotic syndrome and renal impairment initially 2.5 mg/kg daily</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">crosses placenta; see <a title="BNF:target-block: pregnancy immunosuppressant" href="100044.htm#_120500">Immunosuppressant Therapy</a></p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">present in milk—manufacturer advises avoid</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">anorexia, nausea, vomiting, abdominal pain, diarrhoea,
gingival hyperplasia, hepatic dysfunction, hypertension, tremor, headache,
paraesthesia, fatigue, renal dysfunction (renal structural changes
on long-term administration, see also under Cautions), hyperuricaemia,
hyperkalaemia, hypomagnesaemia, hyperlipidaemia, hypercholesterolaemia,
muscle cramps, myalgia, hypertrichosis; <i>less commonly</i> oedema, weight gain, signs of encephalopathy, anaemia, thrombocytopenia; <i>rarely</i> pancreatitis, motor polyneuropathy, menstrual disturbances,
gynaecomastia, microangiopathic haemolytic anaemia, haemolytic uraemic
syndrome, hyperglycaemia, muscle weakness, myopathy, visual disturbances
secondary to benign intracranial hypertension (discontinue); <i>also reported with infusion</i> anaphylaxis</p></div><div class="cAF"><h2>Dose</h2> <p class="cR">Organ transplantation, used alone, <span class="cAK">adult</span> and <span class="cAK">child</span> over 3 months 10–15 mg/kg <span class="cU">by mouth</span> 4–12 hours before transplantation followed by 10–15 mg/kg
daily for 1–2 weeks postoperatively then reduced gradually to 2–6 mg/kg
daily for maintenance (dose should be adjusted according to blood-<span>ciclosporin</span> concentration and renal function); dose lower
if given concomitantly with other immunosuppressant therapy (e.g. <span>corticosteroids</span>); if necessary one-third corresponding
oral dose can be given <span class="cU">by intravenous infusion</span> over
2–6 hours</p><p class="cR">Bone-marrow transplantation, prevention and treatment of graft-versus-host
disease, <span class="cAK">adult</span> and <span class="cAK">child</span> over 3 months 3–5 mg/kg daily <span class="cU">by intravenous infusion</span> over 2–6 hours from day before transplantation to 2 weeks postoperatively
(or 12.5–15 mg/kg daily <span class="cU">by mouth</span>) then 12.5 mg/kg daily <span class="cU">by mouth</span> for 3–6 months then tailed off (may take up to a
year after transplantation)</p><p class="cR">Nephrotic syndrome, <span class="cU">by mouth</span>, 5 mg/kg daily in
2 divided doses; <span class="cAK">child</span> 6 mg/kg daily
in 2 divided doses; maintenance treatment reduce to lowest effective
dose according to proteinuria and serum creatinine measurements; discontinue
after 3 months if no improvement in glomerulonephritis or glomerulosclerosis
(after 6 months in membranous glomerulonephritis)</p><div class="cN"><h3 class="cBP">Important</h3><p>Patients should be stabilised on a particular brand of oral
ciclosporin because switching between formulations without close monitoring
may lead to clinically important changes in blood-ciclosporin concentration.
Prescribing and dispensing of ciclosporin should be by brand name
to avoid inadvertent switching. If it is necessary to switch a patient
to a different brand of ciclosporin, the patient should be monitored
closely for changes in blood-ciclosporin concentration, serum creatinine,
blood pressure, and transplant function.</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li class="jN" id="_213793" style="margin: 0 0 0 20px;"><h1 class="title">Capimune®<span> (<a href="appendix-112803-M.htm#m207352">Mylan</a>)</span> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Capsules</span>, ciclosporin 25 mg (grey),
net price 30-cap pack = £13.80; 50 mg (white), 30-cap pack = £27.00;
100 mg (grey), 30-cap pack = £51.50. 
    Label:
    Counselling, administration<div class="cAO"><span class="cAG">Excipients </span> include propylene glycol (see <a title="BNF:target-block: Excipients" href="29404.htm#_120000">Excipients</a>)</div><div class="cAQ"><div class="cAV"><h3>Note</h3> <p class="cAX">Contains ethanol</p></div><div class="cAV"><h3>Counselling</h3> <p class="cAX">Total daily dose should be taken in
2 divided doses</p></div></div></div></li><li><a href="218363.htm#_218363" title="Capsorin®">Capsorin®</a></li><li><a href="204199.htm#_204199" title="Deximune®">Deximune®</a></li><li><a href="31279.htm#_31279" title="Neoral®">Neoral®</a></li><li><a href="4784.htm#_4784" title="Sandimmun®">Sandimmun®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="217026.htm">Previous: BELATACEPT</a> | <a class="top" href="213793.htm#">Top</a> | <a accesskey="]" href="106034.htm">Next: SIROLIMUS</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>